Numerous studies have pointed out the risks of cocaine use for mental health. Most clinical
studies report a high psychiatric comorbidity, mainly among crack users. In this paper the …

Cocaine remains the second most used illicit drug in Europe, after cannabis, though levels
of use vary between countries. This psychostimulant has become a noticeable part of the …

The aim of this study is to compare the clinical characteristics of three groups of patients in
treatment for cocaine dependence: patients without any psychotic symptoms (NS), patients …

Abstract The Diagnostic Interview Schedule for DSM-IV was used to assess the lifetime
prevalence of psychiatric disorder among not-in-treatment crack cocaine users (N= 313) …

Background: The spread of cocaine and crack use in Europe poses a challenge to the
European health-care systems. The assessment of the extent of the problem as well as the …

An increase in the use of cocaine and crack in several parts of Europe has raised the
question whether this trend is similar to that of the USA in the 1980s. However, research in …

Aim: To investigate differences in alcohol and drug consumption behaviours and related
problems among users of cocaine powder versus crack cocaine. Methods: The sample of …

About 43% was diagnosed with a lifetime mental disorder. The most common diagnoses
were depression (37.5%) and specific phobia (6.8%). During the last 12 months, prevalence …

Aim: The study investigates patterns of cocaine powder and crack cocaine use of different
groups in nine European cities. Design, Setting, Participants: Multi-centre cross-sectional …

Highlights•Both lifetime and current cocaine users show a high prevalence of cocaine-
induced psychosis (CIP).•The prevalence of cocaine-induced psychotic symptoms (CIPS) is …